Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Hancock

Vascular & Interventional Radiology Houston, TX Medical Doctor

NPI 1013143015 CMS profile 182106

2190 North Loop W, Houston, TX 77018

Open in the dashboard

General payments

$12,461

99 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Hancock of Houston, TX is reported in the CMS Open Payments database as having received $12,461 across 99 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,096 26
2024 General $1,512 15
2023 General $1,088 12
2022 General $2,148 17
2021 General $731 11
2020 General $1,547 13
2019 General $339 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Hancock
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to John Hancock were reported at $5,096. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year John Hancock Vascular & Interventional Radiology median Middle half National median
2019 $339 $422 $125–$1,555 $163
2020 $1,547 $200 $68–$652 $114
2021 $731 $280 $99–$866 $132
2022 $2,148 $433 $137–$1,497 $149
2023 $1,088 $506 $152–$2,019 $160
2024 $1,512 $556 $175–$1,930 $164
2025 $5,096 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $8,435 60 payments
  2. Sirtex Medical Inc $1,683 15 payments
  3. Argon Medical Devices, Inc. $886 3 payments
  4. Histosonics, Inc. $529 1 payment
  5. Bard Peripheral Vascular, Inc. $469 6 payments
  6. AngioDynamics, Inc. $100 2 payments
  7. Penumbra, Inc. $93 1 payment
  8. Ethicon US, LLC $76 2 payments
  9. Medtronic, Inc. $59 3 payments
  10. Surefire Medical, Inc. $51 2 payments
  11. Other $81 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $9,030 90 payments
  2. Travel and Lodging $2,181 8 payments
  3. Consulting Fee $1,250 1 payment
Products named General payments · program years 2019–2025
  1. TheraSphere Y90 Glass Microspheres 10 GBq $5,633 38 payments
  2. SIR-Spheres Microspheres $1,336 13 payments
  3. General - Therapies $1,250 1 payment
  4. TIPS $800 1 payment
  5. LAVA LES (Liquid Embolic System) $347 2 payments
  6. EMBOLD Fibered $337 3 payments
  7. COVERA $301 4 payments
  8. THERASPHERE Pain Management $277 5 payments
  9. TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) $273 5 payments
  10. THERASPHERE Embolics $200 3 payments
  11. Other $1,078 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 159 billing codes

Paid by Medicare

$110,161

Medicare's payments for the services billed

Medicare patients

1,726

Average age 74

Services billed

2,506

884 women, 842 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 59%
Arthritis 58%
Chronic kidney disease 54%
Diabetes 48%
Heart failure 46%
Atrial fibrillation 39%
COPD 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

99 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record